| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/04/2010 | US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 05/04/2010 | US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
| 05/04/2010 | US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes |
| 05/04/2010 | US7708984 Using immunoglobulin specific to adenoid expressed chemokine (ADEC) for prevention and treatment of cell proliferative, glandular and viral infection |
| 05/04/2010 | CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators |
| 05/04/2010 | CA2455566C (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 05/04/2010 | CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
| 05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
| 05/04/2010 | CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/04/2010 | CA2367636C Fusion proteins |
| 05/04/2010 | CA2347178C Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing rb2/p130 |
| 05/04/2010 | CA2320467C Cycloalkene derivatives, their production and use |
| 04/29/2010 | WO2010048149A2 Heterocyclic modulators of gpr119 for treatment of disease |
| 04/29/2010 | WO2010047999A2 Method for treating pulmonary arterial hypertension |
| 04/29/2010 | WO2010047669A1 "cholvacor" - a medication in the form of liquid used for regulation of lipid exchange |
| 04/29/2010 | WO2010047453A1 Pharmaceutical composition comprising cilnidipine and telmisartan |
| 04/29/2010 | WO2010047452A1 Pharmaceutical composition comprising lercanidipine and telmisartan |
| 04/29/2010 | WO2010047369A1 Agent for treatment of diabetic nephropathy |
| 04/29/2010 | WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 04/29/2010 | WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010046869A2 Tetrahydronaphthalene compounds |
| 04/29/2010 | WO2010046857A1 Salts of isobutyric acid (1 r*, 2r*, 4r* ) -2- (2-{ [3- (4, 7-dimeth0xy-1 h-benzoimidazol-2-yl) -propyl] -methyl-amino } -ethyl) -5-phenyl-bicyclo [2.2.2] oct-5- en- 2 -yl |
| 04/29/2010 | WO2010046855A1 Bridged tetrahydronaphthalene derivatives |
| 04/29/2010 | WO2010046706A1 Treatment of inflammatory disorders |
| 04/29/2010 | WO2010046297A1 Improving peptide availabilty |
| 04/29/2010 | WO2010045787A1 The use of ginsenoside compound k in the manufacture of atherosclerosis medicine |
| 04/29/2010 | WO2010045755A1 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 04/29/2010 | WO2010045739A1 Process of producing directly compressed tablets of sterols and/or stanols |
| 04/29/2010 | WO2010015335A8 Long-term treatment of symptomatic heart failure |
| 04/29/2010 | WO2010006189A3 Small-molecule inhibitors of hif and angiogenesis |
| 04/29/2010 | WO2010005533A3 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 04/29/2010 | WO2009113741A3 Combination of a carbostyril and carnitine |
| 04/29/2010 | US20100106244 3-Deazaadenosine prevents atherosclerosis and graft vasculopathy |
| 04/29/2010 | US20100105953 Human Adam-10 Inhibitors |
| 04/29/2010 | US20100105946 Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol) |
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105878 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 04/29/2010 | US20100105767 Compounds, compositions and methods |
| 04/29/2010 | US20100105758 Use of an adenosine antagonist |
| 04/29/2010 | US20100105751 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 04/29/2010 | US20100105749 Chemical compounds, pharmaceutical compositions and methods |
| 04/29/2010 | US20100105743 Pharmaceutical compositions and methods for stabilizing the same |
| 04/29/2010 | US20100105733 Treatment of vasomotor symptoms with selective estrogen receptor modulators |
| 04/29/2010 | US20100105732 Piperidine gpcr agonists |
| 04/29/2010 | US20100105727 Novel benzamide derivatives and process for the prepartion thereof |
| 04/29/2010 | US20100105723 5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS |
| 04/29/2010 | US20100105721 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS |
| 04/29/2010 | US20100105712 Chemical compounds |
| 04/29/2010 | US20100105709 6-Butyl-2-methoxy-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-3-phenylpyrimidin-4(3H)-one; for hypertension, cardiac disease, arteriosclerosis, kidney disease, stroke, dyslipidemia, obesity, diabetes, nonalcoholic steatohepatitis, dementia and/or Alzheimer's disease in a mammal |
| 04/29/2010 | US20100105693 Modulators of Muscarinic Receptors |
| 04/29/2010 | US20100105689 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |
| 04/29/2010 | US20100105682 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105665 Renin inhibitors |
| 04/29/2010 | US20100105663 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 04/29/2010 | US20100105650 Substituted isoquinoline and isoquinolinone derivatives |
| 04/29/2010 | US20100105637 Drug-surfactant complexes for sustained release |
| 04/29/2010 | US20100105615 Nutritional Composition To Promote Healthy Development And Growth |
| 04/29/2010 | US20100105613 Therapeutic agent for occlusive peripheral vascular disease, and use thereof |
| 04/29/2010 | US20100105609 Processes for Preparing Eptifibatide |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/29/2010 | US20100104674 Composition for the treatment of hypertension |
| 04/29/2010 | US20100104657 Pharmaceutical composition comprising a reduced concentration of cholesterol |
| 04/29/2010 | US20100104649 Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate |
| 04/29/2010 | US20100104640 Pharmaceutical compositions comprising irbesartan |
| 04/29/2010 | US20100104630 Water soluble statin microstructures and method of preparation |
| 04/29/2010 | US20100104564 Altered Antibody Fc Regions and Uses Thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104541 Method for Preventing and Treating Cardiovascular Diseases with BRCA1 |
| 04/29/2010 | US20100104506 Nanoparticle-Coated Medical Devices And Formulations For Treating Vascular Disease |
| 04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740722A1 Salts of isobutyric acid (1 r*, 2r*, 4r* ) -2- (2-{ [3- (4, 7-dimeth0xy-1 h-benzoimidazol-2-yl) -propyl] -methyl-amino } -ethyl) -5-phenyl-bicyclo [2.2.2] oct-5- en- 2 -yl |
| 04/29/2010 | CA2740430A1 Bridged tetrahydronaphthalene derivatives |
| 04/29/2010 | CA2740364A1 Tetrahydronaphthalene compounds |
| 04/29/2010 | CA2739882A1 Pharmaceutical composition improving intestinal absorption |
| 04/29/2010 | CA2739489A1 Method for treating pulmonary arterial hypertension |
| 04/28/2010 | EP2180049A1 Devices and compositions for lysis of occlusive blood clots while sparing wound sealing clots comprising a mutant pro-urokinase |
| 04/28/2010 | EP2179999A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 04/28/2010 | EP2179994A1 Fused bicyclic compound |
| 04/28/2010 | EP2179740A1 Anti-hypertensive agent |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 04/28/2010 | EP2178874A1 Heterocyclic compounds useful as mk2 inhibitors |
| 04/28/2010 | EP2178835A1 Novel substituted piperidones as hsp inducers |
| 04/28/2010 | EP2178525A1 Resveratrol complex and process for the preperation |
| 04/28/2010 | EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 04/28/2010 | EP1472225B1 2-piperazine-pyridines useful for treating pain |
| 04/28/2010 | EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | CN1923241B Medicine composition containing epimedium extract, uncaria extract, and gastrodine, and its preparation and use |
| 04/28/2010 | CN1872286B Application of medication composition of containing notoginseng in preparing medicine for treating insufficiency of blood supply for brain |
| 04/28/2010 | CN1872276B Application of medication composition of containing extractive of astragalus root in preparing medicine for treating insufficiency of blood supply for brain |
| 04/28/2010 | CN1872068B Application of medication composition of containing acetamino phenol in treating insufficiency of blood supply for brain |
| 04/28/2010 | CN1867578B The conjugates of a hydrophilic polymer-buxus's extracts and the pharmaceutical compositions of thereof |